DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth
DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...
Devdiscourse10h
USDA Scraps Food Safety Committees Amid Oversight Concerns
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
TipRanks on MSN21h
DexCom warning letter ‘not thesis changing,’ says BofA
BofA keeps a Buy rating on DexCom (DXCM) with a $105 price target after Dexcom announced it received a warning letter from the FDA. Importantly, ...
TipRanks on MSN21h
DexCom sees no material impact from warning letter on sales outlook
DexCom (DXCM) does not expect a material impact from the FDA’s warning letter to its manufacturing capacity or its fiscal year 2025 guidance for ...